WallStSmart
APTO

Aptose Biosciences Inc

NASDAQ: APTO · HEALTHCARE · BIOTECHNOLOGY

$1.71
+0.00% today

Updated 2026-04-30

Market cap
$4.36M
P/E ratio
P/S ratio
EPS (TTM)
$-36.38
Dividend yield
52W range
$0 – $0
Volume

Aptose Biosciences Inc (APTO) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20052006200720082009201020112012201320142015201620172018201920202021202220232024
Operating cash flow$-14.92M$-11.87M$-5.88M$-10.25M$-6.62M$-3.53M$-6.03M$-3.21M$-4.94M$-9.94M$-9.89M$-12.17M$-10.22M$-23.21M$-21.56M$-33.89M$-43.30M$-32.32M$-44.59M$-35.98M
Capital expenditures$477614.00$68001.00$19004.00$58332.00$161467.00$1895.00$8257.00$0.00$20275.00$301980.00$258000.00$3728.00$13000.00$329000.00$102000.00$79000.00$212000.00$24000.00$29000.00$5000.00
Depreciation
Stock-based comp$409174.00$409174.00$166805.00$494446.00$492003.00$498699.00$2.41M$2.50M$1.71M$817000.00$4.28M$2.30M$21.44M$12.95M$5.21M$3.65M$1.06M
Free cash flow$-15.40M$-11.93M$-5.90M$-10.31M$-6.78M$-3.53M$-6.04M$-3.21M$-4.96M$-10.25M$-10.15M$-12.18M$-10.24M$-23.54M$-21.66M$-33.97M$-43.52M$-32.35M$-44.62M$-35.98M
Investing cash flow
Financing cash flow
Dividends paid$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Share repurchases
Debt repayment
Net change in cash$4.67M$64.54M$37.55M$-78.28M$-2.14M